Seridol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Seridol

Property Description
Active ingredient Risperidone
Form Oral Tablet, Oral Solution, Injectable Suspension
Pharmacological class Atypical Antipsychotic Agent (SGA)
Common use Managing severe mental and emotional disturbances
Origin Synthetic, Benzisoxazole derivative

Seridol: Classification and Core Identity

Seridol is a pharmaceutical product, manufactured as a brand containing the active ingredient, Risperidone, which is classified as an Atypical Antipsychotic Agent (SGA). This designation is based on its unique neuroreceptor profile, which distinguishes it from older medications. The compound itself is a synthetic substance, specifically a benzisoxazole derivative, created to modulate key chemical pathways in the brain. This class of medication is used for stabilizing thought and emotional processes, serving a role in managing serious mental disturbances. Seridol is a prescription-only medication and is often positioned toward the management of complex, long-term conditions in adults and adolescents, where stabilizing perception is the primary therapeutic focus.


Forms, Composition, and General Purpose

Seridol contains Risperidone as a single active ingredient and is supplied in various dosage forms, including the standard Oral Tablet and Oral Solution. A key differentiating feature is the specialized Long-Acting Injectable Suspension, which is administered via the parenteral route. This injectable format provides sustained, consistent blood levels of Risperidone, which can assist in promoting patient adherence over prolonged periods. Risperidone is a potent monoaminergic antagonist used to manage symptoms related to disrupted perception and behavior. This means the drug helps rebalance chemical messengers in the brain, assisting patients in maintaining a clearer, more consistent grip on reality and supporting overall psychological stability.

Regulatory References

  1. U.S. National Library of Medicine (MedlinePlus)
  2. National Institutes of Health (NIH)

What side effects are possible with Seridol?

Possible Side Effects and Safety Information for Seridol

Seridol, a drug containing the active ingredient diclofenac, is associated with a range of officially documented adverse reactions that affect various body systems. Most commonly reported side effects fall into the Gastrointestinal and Nervous System categories. These often include nausea, vomiting, abdominal pain, diarrhea, dizziness, and headache.

Classification Examples of Adverse Reactions (by System-Organ Class)
Common Nausea, vomiting, diarrhea, dyspepsia, headache, dizziness, vertigo, rash.
Serious Risks Gastrointestinal ulceration, bleeding, and perforation; serious cardiovascular thrombotic events (e.g., heart attack, stroke); severe liver damage (hepatotoxicity); kidney problems (renal toxicity); and anaphylactic reactions.

Serious adverse events can occur without warning and are a key safety focus in regulatory documentation, particularly concerning the cardiovascular and gastrointestinal systems. The risk of serious gastrointestinal events is generally increased with long-term use or higher doses.

Safety Considerations for Specific Populations:

  • Pregnancy: Use of diclofenac is generally not recommended during pregnancy, particularly from the 20th week gestation onward due to potential risks to the fetus (e.g., fetal renal dysfunction and premature closure of the ductus arteriosus).
  • Cardiovascular Risk: Patients with a history of cardiovascular disease or those who have recently undergone heart bypass surgery (CABG) are advised against use due to an increased risk of recurrent CV thrombotic events.
  • Contraindications: Seridol is contraindicated in patients with a known hypersensitivity to diclofenac, aspirin, or other NSAIDs, as well as those with active gastrointestinal bleeding or ulcers, and severe heart failure. Caution is advised for those with existing liver or kidney impairment.

Regulatory authorities require that the lowest effective dose be used for the shortest duration possible to mitigate the potential for serious adverse reactions.

Overdose and Emergency Response

Overdose Manifestations and Emergency Action

Seridol overdose is officially documented to primarily affect the central nervous system (CNS) and the cardiovascular system. Manifestations often involve a depressed level of consciousness, presenting as drowsiness, sedation, or depressed mental status. Movement abnormalities, specifically pronounced extrapyramidal symptoms (EPS) such as dystonia, are also commonly reported signs of over-exposure.

The potential for serious cardiac effects mandates urgent attention. Overdose carries the risk of cardiovascular instability, including hypotension, tachycardia, and the critical electrical abnormality known as QTc prolongation. Severe or life-threatening outcomes documented in regulatory labeling include the potential for seizures, coma, and Neuroleptic Malignant Syndrome (NMS).

Due to the severity of these documented risks, official guidance requires individuals to seek immediate emergency medical attention or contact a poison control service when overdose is suspected. Management is described as symptomatic and supportive, as no specific antidote is known. This management includes maintaining a clear airway and requiring continuous cardiovascular monitoring, including ECG surveillance, until the patient fully recovers from all CNS and cardiac effects. The label notes that pediatric patients using the oral solution face a risk of accidental overdose, and severe renal or hepatic impairment may prolong toxic effects.

Therapeutic Uses of Seridol

What Seridol Treats: Main Uses and Benefits

Seridol (Risperidone) is applied in clinical settings marked by heightened patient distress, offering symptomatic relief across key domains where symptoms related to systemic imbalance disrupt stability. The medication is commonly used across conditions presenting with acute or disruptive episodes, helping to ease the overall symptom burden when symptoms create noticeable interference with daily function.

The medication is relevant for easing challenging symptoms associated with Schizophrenia, acute manic or mixed episodes of Bipolar I Disorder, and Irritability associated with Autistic Disorder (in pediatric patients).

“It is commonly used to help with symptom clusters that may become intense or disruptive, offering supportive relief when stability is challenged.”


Quick Fact: Symptomatic Support for Perceptual Disturbances

Seridol is applied in addressing symptoms that cluster into patterns requiring supportive management, such as hallucinations and delusions. It may assist with maintaining a sense of stability when symptoms are more noticeable, and helps improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Seridol (Risperidone)

The official regulatory documentation for Seridol establishes explicit population boundaries for use, distinguishing between approved groups, those for whom use is contraindicated, and those requiring conditional use.

Absolute Prohibitions and Restrictions

Seridol is contraindicated (must not be used) in patients with a known hypersensitivity to the active ingredient, Risperidone, or to any of the product's excipients. Furthermore, official labeling prohibits its use in elderly patients being treated for dementia-related psychosis.

Age and Condition Eligibility

Eligibility is defined by age thresholds and the specific condition. While adults are generally eligible for schizophrenia and bipolar mania, pediatric use is restricted. The minimum age is 13 years for schizophrenia and 5 years for irritability associated with Autistic Disorder. Use is not recommended during pregnancy or while breastfeeding, as the drug is excreted into human milk.

Conditional use is necessary for patients with impaired organ function. Individuals with moderate to severe renal impairment or hepatic impairment are restricted to a lower starting dose and slower titration, as clearance of the medicine is affected. Caution is also advised for those with underlying cardiovascular disease.

What should I know about interactions with other medicines?

Seridol Interactions with Other Medicines and Products

This section describes interactions with Seridol (Risperidone) as documented in official government regulatory information, focusing on substances that alter exposure or have additive effects.


Official Regulatory Interaction Classifications

Classification Interacting Substance(s) Documented Interaction Pattern
Not Recommended Pimozide, Thioridazine Avoidance advised due to the formally documented risk of QT interval prolongation.
Pharmacokinetic Exposure Change Carbamazepine (Inducer) Decreases the plasma concentration of the total active antipsychotic fraction.
Fluoxetine, Paroxetine (Inhibitors) Increases the plasma concentration of risperidone, with a lesser effect on the total active fraction.
Pharmacodynamic Reinforcement Alcohol (Avoid), Other Centrally-Acting Drugs Additive CNS depressant effects, increasing sedation risk.

Official labeling also notes that Seridol's effect may be antagonized by Levodopa and dopamine agonists. Substances like Cimetidine and Ranitidine may increase risperidone's bioavailability. Furthermore, patients with renal or hepatic impairment demonstrate decreased clearance or increased unbound plasma concentrations, which is a mandatory consideration when assessing potential interaction risks.

Mechanism of Action

Modulating Prostaglandin Synthesis

Seridol's pharmacodynamic action is primarily exerted within the central nervous system (CNS). The drug initiates a signaling cascade by inhibiting the activity of cyclooxygenase enzymes ( COX-1, COX-2, and likely COX-3) predominantly in the neural tissues. This core mechanistic domain modifies early molecular steps by reducing the synthesis of prostaglandins ( PGs), which function as key mediators in neural sensory and thermal pathways. The intracellular consequence of reduced PG production is an elevation of the nociceptive threshold, modulating sensory responses.


Hypothalamic Heat-Regulating Center Adjustment

Seridol influences thermal regulation by affecting the hypothalamic heat-regulating center in the brain. This engagement affects specific signaling pathways involved in core temperature control. The resultant system-level physiological effect is antipyresis (fever reduction), which is mediated by peripheral vasodilation and increased sweating. This cascade leads to dissipation of core body heat, adjusting the body's set point.

Dosage and Administration Information

How to Use Seridol

Seridol (Risperidone) administration follows protocols that define the routes, dosing schedules, and preparation requirements for its various forms. The medicine is supplied as oral tablets, oral solution, orally disintegrating tablets, and as long-acting injectable (LAI) suspensions.

Administration Routes and Schedules

Oral forms are typically taken once daily or in divided doses (twice daily), and may be administered with or without food. The LAI forms are administered parenterally, with deep intramuscular injections scheduled every two weeks, or subcutaneous injections administered on a monthly or bimonthly basis, depending on the product formulation.

Dosing and Titration

For most adults, the standard initial oral dose is 2 mg/day, which is then adjusted (titrated) in small 1–2 mg/day increments, with at least 24 hours between changes, toward a maintenance range of 4–8 mg/day.

Population-Specific Adjustments

Specific treatment protocols involve a specialized starting dose for certain patients. Older adults and individuals with known severe hepatic or renal impairment should initiate treatment with a lower oral dose of 0.5 mg twice daily. Dose increases in these groups proceed more slowly, with adjustments occurring no more frequently than once a week.

Procedural Administration Rules

For the oral solution, it can be mixed with water or coffee, but it is explicitly instructed not to mix it with cola or tea. Patients transitioning to certain bi-weekly LAI forms are required to continue oral supplementation for the first three weeks after the initial injection to ensure consistent medicine levels. Furthermore, the orally disintegrating tablets must not be crushed or chewed.

Recent Clinical Evidence

Research evidence / Overview of studies for Seridol

The research base for Seridol (risperidone) was evaluated in studies exploring conditions where symptoms are marked by functional limitations or periods of heightened symptom activity. The evidence base primarily consists of randomized controlled trials (RCTs), systematic reviews, and long-term observational studies. These findings describe group patterns, not what an individual will experience, and evidence highlights what is known and what is still uncertain.


Evidence for use in Schizophrenia

Clinical evaluations for schizophrenia have was studied for both acute symptom changes and long-term symptom patterns. Short-term trials utilized standardized scales used in research examining the intensity of positive and negative symptoms. Findings describe patterns observed in the studies where research monitored how symptoms evolved in the observed populations during the acute treatment phase. Long-term observational data provided insight into short-term changes for outcomes related to systemic or functional imbalance.

Long-term effects are not fully established regarding cognitive function and daily functioning or activity level. The follow-up durations were limited in many initial trials, and evidence quality varies across studies when comparing long-term strategies. New long-acting injectable formulations have also been evaluated in studies for their ability to promote observed symptom patterns and reduce relapse rates in maintenance treatment.


Evidence in Bipolar I Disorder and Autistic Disorder

Research for Bipolar I Disorder was studied for acute manic or mixed episodes in adults and adolescents. Studies monitored how symptoms evolved over defined short-term intervals, observing outcomes describing episodic or acute changes related to symptom intensity. Data for certain groups remain insufficient regarding sustained effects on depressive symptoms and long-term maintenance in adolescents.

For Autistic Disorder, studies explored outcomes describing episodic or acute changes, such as aggression, irritability, and self-injury, in children and adolescents. This research did not monitor outcomes related to core autistic symptoms like social communication skills. There is limited information for long-term outcomes tracking sustained behavioral patterns beyond the initial, short follow-up periods.


Key limitations and research gaps

A consistent pattern across the indications is that follow-up durations were limited in many of the initial trials. Evidence focusing specifically on improving daily functioning or quality of life is less common than evidence focused on measuring core symptoms. Sample sizes were modest in some key early trials, and comparative evidence is lacking in some areas. Research is ongoing, but for now, evidence remains limited in these specific areas.

Key Studies & References

  1. NICE Guideline: Psychosis and schizophrenia in adults: prevention and management

Frequently Asked Questions (FAQ)

Common questions about Seridol (FAQ)

Q: How quickly does Seridol start working for most people?

A: Studies and official documents indicate that the effect of Seridol on symptom patterns is typically measured over the initial weeks of acute treatment. The full therapeutic effects are generally measured over several weeks of ongoing use, according to research.


Q: Is Seridol safe for older adults (seniors)?

A: Official product information notes that a lower starting dose is generally recommended for older adults due to possible changes in how the body processes the medication. The use of this medication is contraindicated in elderly patients with dementia-related psychosis, as stated in the label.


Q: How long can a person safely take Seridol?

A: Official documents describe that the risk of certain serious side effects may increase when taking Seridol for an extended period. Long-term effects beyond the duration of initial clinical trials are areas where data may be limited, according to regulatory summaries.


Q: Are there specific foods or drinks that should be avoided when using Seridol?

A: Regulatory information specifies that if using the oral solution, it is advised not to mix it with cola or tea, as instructed in the product information. Additionally, Alcohol consumption is advised against, as it may contribute to additive effects like drowsiness.


Q: Can Seridol be used by people with a history of heart problems?

A: Official labeling advises that caution should be exercised when Seridol is used by individuals with a history of underlying cardiovascular disease (heart and blood vessel issues).


Q: Are there any long-term side effects associated with Seridol use?

A: Regulatory documents note that the risk of some serious adverse reactions, such as gastrointestinal events, is generally increased with long-term use. Information regarding cognitive function and daily functioning over very extended periods is limited in the current research summaries.


Q: What is the experience of patients who have used Seridol for many years?

A: Research evidence found in official sources primarily describes the patterns observed in studies that had defined, time-limited follow-up durations. Comprehensive information regarding sustained patient experiences extending over many years is generally not available within initial regulatory filings.


Q: Can Seridol be taken with antacids or heartburn medicine?

A: Official drug interaction information notes that certain medications used to treat heartburn, specifically Cimetidine and Ranitidine, may cause the concentration of Seridol in the body to increase. This information indicates the need for monitoring when these substances are used together.


Q: What is the typical timeframe for seeing the full benefits of Seridol?

A: Studies and official documents indicate that the effect of Seridol on symptom patterns is typically measured over the initial weeks of acute treatment. The full therapeutic effects are generally measured over several weeks of ongoing use, according to research.


Q: Does Seridol make other medications less effective?

A: Regulatory information notes that the overall effect of Seridol may be lessened (antagonized) by other substances, such as Levodopa and certain dopamine agonists. The potential for Seridol to lessen the effectiveness of other medications is documented in official interaction profiles.


Q: What should I do if I miss a dose of Seridol?

A: Official guidance defines the procedure for a missed dose and generally suggests taking it as soon as it is remembered, unless it is close to the time for the next scheduled dose.


Q: Can Seridol make me feel tired or drowsy?

A: According to the official adverse reactions list, drowsiness (somnolence) is a commonly documented side effect of Seridol. The drug may also have additive effects with other centrally-acting medications, potentially increasing feelings of sedation or tiredness.


Q: Are there any common over-the-counter medicines that interact with Seridol?

A: Official regulatory documents provide general warnings against the combined use of Seridol with Alcohol and Other Centrally-Acting Drugs, which may include some over-the-counter medicines. Patients should review the official label for any specific named substances and consult the label before starting any new medication.


Q: Does Seridol cause weight gain?

A: Weight gain is a change in body weight that is frequently listed as an officially documented adverse reaction associated with Seridol and its class of medication.


Q: Will I have withdrawal symptoms if I stop taking Seridol suddenly?

A: Official regulatory information includes warnings regarding the potential for discontinuation symptoms to occur if Seridol is stopped suddenly. The product label often advises that gradual reduction, rather than an abrupt halt, is generally recommended for discontinuation.


Q: Can Seridol affect my ability to drive or operate machinery?

A: Because Seridol may cause side effects like dizziness or drowsiness, official warnings note that patients should use caution when engaging in hazardous activities. This includes tasks that require mental alertness, such as driving or operating machinery.


Q: Does Seridol have a risk of dependence or addiction?

A: Regulatory labeling for Seridol's class of medication generally includes a section on Dependence and notes that this drug is typically not associated with addiction or dependence.


Q: Does Seridol affect blood pressure?

A: The official adverse reaction documentation commonly includes effects on blood pressure. This includes reports of orthostatic hypotension, which is a drop in blood pressure that can occur when a person stands up quickly from a sitting or lying position.


Q: How long does Seridol stay in your system?

A: Regulatory documents contain detailed information on the drug's pharmacokinetics (how the body handles the drug), including the elimination half-life of the active compound. The half-life is a measure of the time it takes for the concentration of the drug in the body to be reduced by half.


Q: What should I tell my doctor before starting Seridol?

A: The official product label includes a list of medical conditions, current medications, and health statuses that patients should report to their healthcare provider before beginning treatment. This often includes known allergies, existing heart conditions, and pregnancy or breastfeeding status.


Q: Does Seridol interact with birth control pills?

A: Regulatory drug interaction documentation may include information on whether Seridol affects the enzymes that process hormonal contraceptives (birth control pills). This information indicates the potential for altered concentrations of one or both medications in the body.


Q: Why do people who stop taking Seridol sometimes feel worse initially?

A: Official regulatory information recognizes the potential for discontinuation symptoms to occur if the medication is stopped abruptly. These temporary effects are generally managed by gradually reducing the dose under supervision, as advised in the product information.


Q: Are there different strengths of Seridol available?

A: Yes, the regulatory documents explicitly list all the available dosage strengths and package sizes for each of Seridol's formulations, including the oral tablets, oral solution, and injectable suspensions.


Q: Is Seridol a controlled substance?

A: The official regulatory classification, determined by governmental bodies, confirms whether Seridol is listed as a controlled substance (e.g., Schedule I, II, III, IV, or V). This classification indicates its potential for non-medical use or dependence.


Q: What happens if I take too much Seridol?

A: Regulatory labels contain a dedicated section on Overdosage. This section describes the clinical features, signs, and symptoms that have been observed in cases of overdosage.


Q: Does Seridol affect sleep patterns?

A: According to the official adverse reactions list, Seridol is associated with effects on sleep patterns. These commonly documented reactions include both insomnia (difficulty sleeping) and somnolence (drowsiness or increased sleepiness).


Q: Does Seridol require regular blood tests?

A: Regulatory labeling specifies if routine laboratory monitoring is recommended or required during treatment with Seridol. These tests may include monitoring factors such as liver function, kidney function, or blood cell counts.


Q: What is the half-life of Seridol?

A: Official regulatory documents provide the measured elimination half-life for Seridol and its active metabolite. This pharmacokinetic value represents the time required for the concentration of the substance in the body to decrease by fifty percent.


Q: Does Seridol interact with herbal supplements like St. John's Wort?

A: Official regulatory documents often include warnings regarding interactions with potent herbal supplements, such as St. John's Wort. These supplements can affect the body's enzyme systems, which may alter the exposure level of Seridol.


Q: Is Seridol known to cause sexual side effects?

A: Sexual dysfunction, which can include changes in libido or erectile function, is a commonly documented adverse reaction for Seridol and its drug class, as described in official regulatory lists.


Q: Is Seridol used in combination with other drugs?

A: While the product label provides a detailed description of known drug interactions, efficacy trials for Seridol often include patients who are taking concomitant medications (other drugs). However, specific combination treatment protocols are determined clinically.


Q: Are the side effects of Seridol temporary or permanent?

A: Adverse reaction profiles often describe most effects as transient (short-term) or reversible upon stopping the medication. However, official warnings also address the potential for rare, irreversible effects, such as Tardive Dyskinesia, which are listed in the required safety information.


Q: Does Seridol have a black box warning?

A: Regulatory labels clearly state the presence and content of any Black Box Warnings—the most serious level of warning required by the FDA. This warning highlights important safety information that healthcare providers and patients must consider.


Q: Is Seridol a new or established medication?

A: The regulatory label includes the Date of Initial FDA Approval (or equivalent governmental authorization), which confirms the date the drug was first allowed onto the market. This date establishes whether it is a new or established treatment.


Q: Is Seridol safe for children or adolescents?

A: Official regulatory information specifies the conditions for use in the pediatric population. The label defines the specific minimum age and the particular conditions for which Seridol is authorized for use in children and adolescents.

How should Seridol be stored and disposed of?

Seridol (risperidone) must be stored according to specific, documented regulatory guidelines to maintain its stability and effectiveness.

Storage Conditions

Detail Official Requirement
Temperature Store at controlled room temperature, typically below 30 C (86 F) [Source 1.6, 1.4].
Handling Do not refrigerate or freeze the oral solution or tablets [Source 1.1, 1.3].
Protection Keep the medicine in its original, tightly closed container, and protect from light and moisture [Source 1.4, 1.3].
Stability Limit The Oral Solution must be discarded 4 months after first opening [Source 3.2].
Child Safety Keep out of the sight and reach of children [Source 1.3, 1.1].

Disposal Instructions

Official instructions require the disposal of unused or expired medicine [Source 1.3]. Seridol should be disposed of by taking advantage of community drug take-back programs or by following the U.S. FDA's guidance for non-flush list medicines, which involves mixing the medicine with an unappealing substance (like coffee grounds or dirt) and placing it in a sealed container before discarding it in the household trash [Source 2.1]. Do not dispose of Seridol via wastewater unless specifically directed by the drug's labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seridol found in:

A-Z Index: